ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿Ç⠺м® : ÀÓ»óÀÇÇÐºÐ¾ß 2019³â 6¿ù Å°¿öµå ºÐ¼®
2019³â 6¿ù ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿ÇâÀ» ÆľÇÇϱâ À§ÇÏ¿© ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ´Â ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇко߸¦ Æ÷ÇÔÇÏ¿© 6°³ ºÐ¾ßÀÇ Å°¿öµå ºÐ¼®À» ¼öÇàÇÏ¿´´Ù. Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿¡¼ ÃßÃâµÈ ³í¹®À» ¹ÙÅÁÀ¸·Î Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2019³â 6¿ù¿¡ ¹ßÇ¥ÇÑ ±¹³» Àú³Î ³í¹®°ú ¹Ì±¹ ±¹¸³º¸°Ç¿ø PubMed DB¿¡ À妽ºµÈ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´´Ù. Àüü 3,274Æí Áß¿¡¼ ÀÓ»óÀÇÇко߿¡ ÇØ´çÇÏ´Â ³í¹®Àº 1,549ÆíÀ¸·Î ÀüüÀÇ 47.3%¸¦ Â÷ÁöÇÏ¿´À¸¸ç À̸¦ 5¿ù(n=1,545)°ú ºñ±³ÇÏ¿© º¼ ¶§ Å« Â÷À̸¦ ³ªÅ¸³»Áö ¾Ê¾Ò´Ù.
6¿ù ÀÓ»óÀÇÇкоßÀÇ ±¹³» ±¹¿Ü ³í¹®¹ßÇ¥ ÀúÀÚ°¡ ÀÔ·ÂÇÑ Å°¿öµå¸¦ ±âº»À¸·Î ÇÏ¿© ºÐ¼®ÇÑ °á°ú´Â AMP-Activated Protein Kinases, Area Under Curve, BMI, Chronic Obstructive Lung Disease, DNA, Electroencephalography, End-Stage Kidney Disease, female, Interleukin-6, LC-MS, MicroRNAs, Nutrition Surveys, Ovarian cancer, PET, Polymerase Chain Reaction, Prostaglandins A, RNA, Serum, Side effects, Stability µîÀÇ Å°¿öµå°¡ »óÀ§·Î ÃâÇöÇÏ¿´´Ù. ÀÓ»óÀÇÇÐºÐ¾ß 6¿ù Å°¿öµå ¿¬±¸µ¿ÇâºÐ¼®Àº Çѱ¹ ¿¬±¸ÀÚ°¡ ¹ßÇ¥ÇÑ KMbase (Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º) ±âÁØÀ¸·Î ±¹³» Àú³Î¹ßÇ¥ 822Æí, ±¹¿Ü Àú³Î¹ßÇ¥(PubMed ±âÁØ) 727ÆíÀ¸·Î ÃÑ 1,549ÆíÀÌ ºÐ¼®´ë»óÀ¸·Î ÀÌ¿ëµÇ¾ú´Ù.
±×¸² 1. Çѱ¹ÀÇ°úÇÐ ¿¬±¸µ¿ÇâºÐ¼® : ÀÓ»óÀÇÇÐ ºÐ¾ß 6¿ù Å°¿öµåµ¿Çâ
Ç¥ 1. ÀÇ°úÇÐ ÃֽŠ¿¬±¸µ¿Ç⠺м® : ÀÓ»óÀÇÇÐºÐ¾ß 2019³â 6¿ù ¿¬±¸µ¿Ç⠺м®
(KMbase: Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º 2019³â 5¿ù ±¹³»,±¹¿ÜÀú³Î ¹ßÇ¥±âÁØ n=1,549)
Å°¿öµå ¼øÀ§
|
ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ Å°¿öµå
|
1
|
Side effects
|
2
|
PET
|
3
|
BMI
|
4
|
Female
|
5
|
DNA
|
6
|
Area Under Curve
|
7
|
End-Stage Kidney Disease
|
8
|
Chronic Obstructive Lung Disease
|
9
|
Interleukin-6
|
10
|
Serum
|
11
|
Nutrition Surveys
|
12
|
LC-MS
|
13
|
AMP-Activated Protein Kinases
|
14
|
Electroencephalography
|
15
|
ovarian cancer
|
16
|
Prostaglandins A
|
17
|
Stability
|
18
|
RNA
|
19
|
Polymerase Chain Reaction
|
20
|
MicroRNAs
|